Theravance Biopharma, Inc. (TBPH)
NASDAQ: TBPH · Real-Time Price · USD
16.58
-0.13 (-0.78%)
At close: Jun 18, 2026, 4:00 PM EDT
16.50
-0.08 (-0.48%)
After-hours: Jun 18, 2026, 4:22 PM EDT
Theravance Biopharma Market Cap
Theravance Biopharma has a market cap or net worth of $854.75 million as of June 18, 2026. Its market cap has increased by 55.27% in one year.
Market Cap
854.75M
Enterprise Value
500.59M
1-Year Change
55.27%
Ranking
Category
Stock Price
$16.58
Market Cap Chart
Since May 16, 2014, Theravance Biopharma's market cap has increased from $740.70M to $854.75M, an increase of 15.40%. That is a compound annual growth rate of 1.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 854.70M | -9.85% |
| Dec 31, 2025 | 948.10M | 104.91% |
| Dec 31, 2024 | 462.70M | -17.33% |
| Dec 29, 2023 | 559.70M | -25.95% |
| Dec 30, 2022 | 755.80M | -7.20% |
| Dec 31, 2021 | 814.40M | -28.37% |
| Dec 31, 2020 | 1.14B | -22.64% |
| Dec 31, 2019 | 1.47B | 3.64% |
| Dec 31, 2018 | 1.42B | -6.02% |
| Dec 29, 2017 | 1.51B | -8.88% |
| Dec 30, 2016 | 1.66B | 166.99% |
| Dec 31, 2015 | 620.20M | 28.99% |
| Dec 31, 2014 | 480.80M | -35.09% |
| May 16, 2014 | 740.70M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arbutus Biopharma | 898.80M |
| Lexicon Pharmaceuticals | 892.83M |
| Alpha Tau Medical | 881.92M |
| Kura Oncology | 881.53M |
| ORIC Pharmaceuticals | 878.86M |
| Janux Therapeutics | 867.20M |
| Phathom Pharmaceuticals | 864.20M |
| LB Pharmaceuticals | 860.30M |